Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Highlights

A collection of news and information related to National Institute of Arthritis and Musculoskeletal and Skin Diseases published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-3 of 3
» View wsbt.com items only
    Feb 27, 2012 |Story| Los Angeles Times

  1. In-Your-Face Fitness: Keeping your lower back pain-free

    On a recent ski trip, my best friend handed me a flask of cinnamon schnapps. He called it "courage in 100-proof form," and I needed it. I was perched at the edge of a cliff, looking at a 20-foot drop into thigh-deep powder.
    On a recent ski trip, my best friend handed me a flask of cinnamon schnapps. He called it "courage in 100-proof form," and I needed it. I was perched at the edge of a cliff, looking at a 20-foot drop into thigh-deep powder. Nearly a decade ago, when I...

    Tags: Internal Medicine, Health, Back Pain, Personal Service, Medical Specialization

    2. Jun 21, 2010 |Story| Hartford Courant

  2. What causes back pain, and how to prevent it

    It can happen while you're hauling boxes to the attic, gardening in the yard or even sitting in front of a computer too long.
    Hartford Courant
    It can happen while you're hauling boxes to the attic, gardening in the yard or even sitting in front of a computer too long. Back pain: It's one of the most common medical problems in the United States, according to the National Institutes of Health....

    Tags: Health, Back Pain, Health Organizations, Orthopedic Surgery, Arthritis

    3. Jul 6, 2010 |Story| Los Angeles Times

  3. The Pros and Cons of Prolia

    The U.S. Food and Drug Administration recently approved a new drug for osteoporosis. Amgen's Prolia (denosumab) prevents fractures in postmenopausal women at a rate similar to the most popular drugs on the market — bisphosphonates such as Fosamax, Actonel, Boniva and Reclast.
    Special to the Los Angeles Times
    The U.S. Food and Drug Administration recently approved a new drug for osteoporosis. Amgen's Prolia (denosumab) prevents fractures in postmenopausal women at a rate similar to the most popular drugs on the market — bisphosphonates such as Fosamax,...

    Tags: Fosamax (drug), Health, Post Menopause, Amgen Inc., Mayo Clinic

Original site for National Institute of Arthritis and Musculoskeletal and Skin Diseases topic gallery.